Back to results
US 2013/0171252 A1Published application
Formulation Comprising a Type B Lantibiotic
AssigneeNovacta Biosystems Limited
InventorsAntony Nicholas Appleyard, Sjoerd Nicolaas Wadman
Life of this patent
Estimating the term…
Abstract
Described is a pharmaceutical formulation of a capsule for oral delivery of a type B lantibiotic to the stomach comprising a hard gelatine, HPMC or starch capsule, and a type B lantibiotic of formula (I): wherein X is —NH(CH2)qNH2 and q is an integer 2 to 12.
Claims36
-38. (canceled)
A pharmaceutical formulation of a capsule for oral delivery of a type B lantibiotic to the stomach comprising:
- a rapidly disintegrating capsule;
- a type B lantibiotic of formula (I):
- wherein
- X1-X2 is selected from the group consisting of Leu-Leu, Leu-Ile, Leu-Val, Ile-Leu, Ile-Ile, Ile-Val, Val-Ile and Val-Leu;
- X is —NH(CH2)qNH2;
- q is an integer 2 to 12;
- Z is —NR1R2;
- R1 is H or C1-4 alkyl,
- R2 is H, an amino acid or C1-4 alkyl, and
- p is 0 or 1, or
- a pharmaceutically acceptable salt or solvate thereof,
- wherein the capsule releases the type B lantibiotic into the stomach.
9 more elements
Dependencies are inferred from the claim text.